Aptevo Therapeutics APVO
NASDAQ APVO
$1.76 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aptevo Therapeutics (APVO) Gains from Sales and Divestitures (2017 - 2021)

Updated

Aptevo Therapeutics (APVO) recorded Gains from Sales and Divestitures of -$47,000 in FY2022, compared with -$4,000 in FY2021.

Analysis

Aptevo Therapeutics (APVO) Gains from Sales and Divestitures (2017 - 2021) Analysis & Trends

Starting with FY2017, Aptevo Therapeutics' Gains from Sales and Divestitures history includes 5 years.

  • The FY2022 figure is the lowest annual Gains from Sales and Divestitures in data going back to FY2017.
  • Per Business Quant data, APVO's Gains from Sales and Divestitures was -$4,000 in FY2021, $14.34 million in FY2020 (+237.4%) and $4.25 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Aptevo Therapeutics 2.50 Mn -64.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 1,000.00
Mar 31, 2021 -5,000.00
Jun 30, 2020 38,000.00
Mar 31, 2020 14.30 Mn
Dec 31, 2017 159,000.00
API Access

Aptevo Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=APVO&period=max&api_key=YOUR_API_KEY